According to the report of 360iResearch market of biosimilars is expected to reach 31,872.68 million US$ by the year 2025 form the 6,738.15 million US$ of the year 2018 with the CAGR of 24.86%. The report includes all the factors affecting the market of biosimilars on a global scale.
The market of biosimilars is segmented based on different diseases and disorders. Oncology is expected to hold the market with the highest growth rate from 2019 to 2025. On the base of the manufacturing process, in-house manufacturing is expected to hold the largest market share while Contract Manufacturing has the potential to grow at the highest CAGR during the forecast period. On the base of product type, Recombinant Glycosylated Proteins is expected to hold the highest market share and will have the highest growth rate in the forecast period.
The regions covered in this report include Europe, Americas, Middle East & Africa and the Asia Pacific. The Asia Pacific is anticipated to have the highest growth rate in the forecast period. Europe, Middle East & Africa dominates the market in term of market share. The factors affecting market growth in these regions are taken into consideration for complete analysis. Major manufacturers of biosimilars are included in the analysis along with the complete business strategy and product details.